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Abstract
A critical step in biochip design is the selection of probes with identical hybridisation characteristics. In this article we
describe a novel method for evaluating DNA hybridisation probes, allowing the fine-tuning of biochips, that uses cassettes
with multiple probes. Each cassette contains probes in equimolar proportions so that their hybridisation performance can
be assessed in a single reaction. The model used to demonstrate this method was a series of probes developed to detect
TORCH pathogens. DNA probes were designed for Toxoplasma gondii, Chlamidia trachomatis, Rubella, Cytomegalovirus, and
Herpes virus and these were used to construct the DNA cassettes. Five cassettes were constructed to detect TORCH
pathogens using a variety of genes coding for membrane proteins, viral matrix protein, an early expressed viral protein, viral
DNA polymerase and the repetitive gene B1 of Toxoplasma gondii. All of these probes, except that for the B1 gene,
exhibited similar profiles under the same hybridisation conditions. The failure of the B1 gene probe to hybridise was not due
to a position effect, and this indicated that the probe was unsuitable for inclusion in the biochip. The redesigned probe for
the B1 gene exhibited identical hybridisation properties to the other probes, suitable for inclusion in a biochip.
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Introduction
DNA microarray technology has been widely used in gene
expression analysis, environmental monitoring, and disease
characterization. In particular microarrays have allowed the
detection of mutations in specific genes that are recognized as
diagnostic ‘‘markers’’ for the onset of particular diseases (p53 in
GeneChip; HIV in GeneChip, Affimetrix) [1]. In addition, low-
density biochips have been developed and used successfully to
check the identity of pathogens when detecting disease origins.
Examples of this include a biochip for monitoring six sexually
transmitted pathogens [2], and one that specifically detects point
mutations in the gyrA and parC genes of Neisseria gonorrhoeae that are
involved in the formation of ciprofloxacin resistance [3]. A multi-
target biochip is ideal for detecting a set of pathogens that cause
similar symptoms and co-infections, or that are harmful to the
same extent, whether they are encountered singularly or all
together [4,5]. Evaluating multi-target probes can be time
consuming, necessitating the need to develop a way of processing
a large number of probes simultaneously.
The rate-limiting step in the establishment of a diagnostic
biochip is the evaluation of its probes. These probes have to satisfy
several requirements such as a uniform melting temperatures (Tm)
and being a similar size so that their signal intensities are
comparable under the same hybridization conditions. The
theoretical profiles of probes, however, are often inconsistent with
experimental data, and this can generate biochips with irregular
signal responses. It has been estimated that between 21–34% of
probes do not match their intended targets [6]. The consequence
of this is often the redesign of biochips, costing time before the
microarray is fully effective. Using a probe cassette, we have
developed a system for testing multiple probes simultaneously so
that those with inconsistent hybridization behaviours can be easily
identified.
The cassette approach we adopted for probe evaluation allowed
multiple sets of oligonucleotides for different genes to be assessed
simultaneously under standard hybridization conditions. The
cassettes comprise a tandem arrangement of probes, which act
as the target DNA, permitting copy number control in standard
reactions, so that poorly performing probes can be rapidly
identified. As the model for fine-tuning the binding affinity of
probes to their target DNA we have used a biochip designed for
the identification of 5 pathogens involved in TORCH infections
(Toxoplasma gondii, Chlamydia trachomatis, Rubella, Cytomegalovirus,
Herpes virus). The matrix used for the biochip was a three-
dimensional one suitable for depositing a large number of probes
[7].
In order for the application of biochips to become routine,
flexible and reliable methods that allow probe design and
evaluation need to be developed. In this paper we describe a
simple and reliable method to evaluate DNA probes using a
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cassette approach that is applicable to different types of biochips
and microarray.
Materials and Methods
Probe design and biochip preparation
De novo probes were designed for the following targets: the B1
gene of Toxoplasma gondii; the major outer membrane protein
(MOMP) gene and a cryptic plasmid sequence of Chlamydia
trachomatis; the envelope protein E1 gene of Rubella virus (RV); the
immediate early gene (IE) and the phosphorylated matrix protein
pp65 gene of human Cytomegalovirus; and the DNA polymerase
gene of the Herpes Simplex Viruses type 2 (HSV-2). The character-
istics of probes are shown in the Table 1. Each probe was modified
by the inclusion of 3-methyluridine at the 39-end (Bioneer Co.,
Daejeon, Korea) and activated by treatment with NaIO4,
producing dialdehyde groups that couple with hydrazine groups
in the gel matrix [8]. All oligonucleotides were checked for their
ability to form secondary and tertiary structures using the IDT
Oligo Analyzer programme. Probes were chosen from those
ologonucleotides that had similar hairpin formation properties
above and below the hybridization temperature.
The biochip (0.660.6 cm) consisted of 565 circular polyacryl-
amide gel pads, 0.8 mm60.04 mm, separated by 0.7 mm and
fixed on a glass plate. The matrix comprised 9 mM N,N-
dimethylacrylamide, 1 mM 2-hydroxyethylacrylate and 0.2 mM
N,N methylene–bis-acrylamide, TEMED, glycerol and methylene
blue, which was polymerized after UV light treatment and
activated by hydrazine hydrate treatment [8]. Activated oligonu-
cleotides (250 pmol) were coupled with the gel pads and two
replicate spots of each probe applied to the biochip. The matrix
was covered in oil (Immersion oil microscopy grade, AppliChem,
Germany) and incubated at 20-25uC for 48 hrs.
Cassette construction
Five cassettes were synthesized to evaluate the different probes
(see Data S1). Cassette N1 (105 bp) contained three probe
sequences for Chlamydia trachomatis; two for the major outer
membrane protein (CT1 and CT2) and one for the cryptic
plasmid (CT3). Cassette N2 (139 bp) had the probe sequences for
the immediate early protein (CMV1) and the phosphorylated
matrix protein pp65 (CMV2) of Cytomegalovirus, DNA polymerase
of Herpes simplex virus type 2 (HSV), the B1 gene of Toxoplasma gondii
(TOXO1), and the envelope protein of Rubella virus (RV). Cassette
N3 had the same probe sequences as cassette N2 but in a different
order. Cassette N4 (125 bp) contained four different probe
sequences for gene B1 of Toxoplasma gondii (TOXO1, TOXO2,
TOXO3 and TOXO4). Cassette N5 (141 bp) contained five
probes (CT1, CMV2, HSV, RV, TOXO2) for detection of each
pathogen. All ssDNA cassettes contained the sequencing T7
primer at 59-end (sense orientation) and the sequencing SP6
primer at 39-end (antisense orientation).
PCR amplification of cassettes
The cassettes were amplified from ssDNA using forward T7 (59-
GTA ATA CGA CTC ACT ATA GGG-39) and reverse SP6 (59-
TAC GAT TTA GGT GAC ACT ATA G-39) primers. The SP6
primer was modified by the attachment of a fluorescent dye, Cy3,
to its 59 ends, for detection purposes. The high-fidelity DNA
polymerase (iProof High-Fidelity DNA polymerase, Bio-Rad) was
used to amplify all cassettes. The reactions were initiated by
denaturation at 98uC for 30 seconds followed by 35 cycles of 10
seconds at 98uC, 20 seconds at 55uC, 10 seconds at 72uC and a
final extension for 10 minutes at 72uC.
Hybridization and analysis
The probes were evaluated by hybridizing them against
oligonucleotide cassettes containing the probe sequences. The
cassettes were amplified using PCR and the purified products
(QIAquick PCR Purification Kit, Qiagen) were suspended in the
hybridization buffer (1 M GuSCN, 50 mM HEPES [pH 7.5],
5 mM EDTA) at a concentration of 100 pmol, heated at 95uC for
5 minutes then quickly quenched on ice and hybridized against the
biochip at 45uC in the presence of 0.2 mg/ml bovine serum
albumin for 3 hours. The biochips were washed twice with 2X
SSC +0.2% SDS at 25uC for 5 minutes, followed by a single wash
in 2X SSC at 25uC for 1 minute. The fluorescent patterns were
recorded using a Portable Imager 5000 (Aurora Photonics, USA).
The negative controls for all hybridization reactions were those
probes present on the biochip that were not being evaluated
because they were absent in the cassette. In addition to this, DNA
Table 1. Characteristics of the probes used in this study.
Probe name Target Species Gene name GenBank accession no Sequence 59R39 Tm 6C G+C %
CT1 Chlamydia trachomatis MOMP X55700 GGA GAT AAT GAG AAC CAT
GCT AC
59.1 43.5
CT2 Chlamydia trachomatis MOMP X55700 TCT ATG GGA AGG TTT CGG C 60.0 52.6
CT3 Chlamydia trachomatis Cryptic plasmid X07547 TCA CCA CCT ACA CGG AAA CA 60.0 50
TOXO1 Toxoplasma gondii B1 AF179871 CCG GAA ATA GAA AGC CAT G 60.0 47.5
TOXO2 Toxoplasma gondii B1 AF179871 GTA TTC GCA GAT TGG TCG C 59.2 52.6
TOXO3 Toxoplasma gondii B1 AF179871 GGT GAC GAA AGG GGA AGA AT 60.3 50.0
TOXO4 Toxoplasma gondii B1 AF179871 CCT GTT TCC TCT CTT CAC TGT C 58.0 50.0
CMV1 Cytomegalovirus IE M11630 K01090 ATA AGC GGG AGA TGT GGA TG 59.9 50.0
CMV2 Cytomegalovirus pp65 M15120 GCG GTG TGC TTT ATT AGG G 58.3 52.6
HSV Herpes simplex virus DNA polymerase M16321 TTA TCA ACC GCA CCT CCA G 58.6 52.6
RV Rubela virus E1 JX047998 AAC GCC ATT CCC CTG ACT 60.5 50.0
DBAC Desulfobacter spp. 16S rRNA Y14745 GAT AAT CTG CCT TCA AGC
CTG G
60.0 50.0
doi:10.1371/journal.pone.0098596.t001
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from Desulfobacter spp. was used as the negative control (Figure 1
e5). Under these circumstances, no cross-hybridisation of the
probes was detected. The fluorescent signal intensity of gel
elements without immobilized probes was estimated before and
after hybridization and used to calculate the median background
signal value (Figure 1 c5, d5). The signal intensity of each gel
element on the biomatrix was calculated with MicroChip Imager
software (Aurora Photonics, USA).
Results and Discussion
Five cassettes (N1 to N5) were used to evaluate the hybridization
potential of each probe. The number of probes included in each
cassette ranged from 3 to 5, and the size varied from 105 to
141 bp. The evaluating power of the system can be increased by
synthesizing cassettes with a greater number of probes of variable
size. Hybridization reactions with the activated biochip were
performed under conditions where target DNA and oligonucleo-
tide concentrations were similar, so that the influence concentra-
tion on the reaction was negliable. The hybridization behaviours
of the Chlamydia trachomatis probes were assessed using cassettes N1.
All of the probes exhibited comparable hybridization capacities
(Figure 1A), indicating that each of these probes were suitable for
inclusion in the biochip.
The probes for the Cytomegalovirus genes coding for the
immediate early protein (CMV1) and the matrix protein pp65
(CMV2), the DNA polymerase of Herpes simplex virus (HSV), the B1
protein of Toxoplasma gondii (TOXO1), and the envelope protein
E1 of Rubela virus (RV) were evaluated using cassettes N2
(Figure 1B). Four probes (CMV1, CMV2, HSV and RV) exhibited
similar hybridization profiles, whereas the fifth probe (TOXO1)
failed to detect its antisense strand. The failed probe was situated
at the forth position in cassette N2. To ascertain whether the
position of the probe in the cassette influenced its hybridization
capacity, we designed cassette N3, where the failed probe was
located at the beginning of the cassette. The hybridization
behaviour of the N3 cassette did not differ from cassette N2
(Figure 1B), indicating that its hybridization signal was indepen-
dent of sequence position in the cassette. Probe TOXO1 did,
however, hybridize with its single-stranded compliment labeled
with a fluorescent dye, Cy3, at the 59- end (data not shown). This
suggested that this probe for the B1 gene needed to be redesigned.
We designed three different probes for the B1 gene from
Toxoplasma gondii, and synthesized a new cassette, N4 containing all
of the probes including TOXO1. The hybridization pattern of
cassette N4 showed that probe TOXO1 failed to produce a signal
again, confirming that it was not suitable for inclusion in the
biochip (Figure 1C). All of the other N4 probes had similar
hybridization profiles, any one of which could replace the failed
probe. Although all of these probes had similar properties,
satisfying the best physico-chemical conditions for hybridization,
they exhibited different efficiencies, which were revealed using our
cassette evaluation system.
The construction of cassette N5 completed the optimization of
this system. This cassette contained a redesigned probe for gene
B1 (TOXO2) with the other probes. Each of these probes behaved
in a similar fashion when hybridized to their target under the same
hybridization conditions (Figure 1D).
In this short communication we describe a practical, emprical
approach to the evaluation of probes, ensuring that they share
hybridisation characterisitcs so that they can be included in a
biochip. The main advantage of the approach is the ability to
distinguish the hybridisation capacities of different probe sequenc-
es present in equimolar proportions in one long DNA fragment.
The method was assessed using five variants, hybridised under the
same conditions. Variation in hybridisation intensity is to be
expected if the probes have different denaturation/reassociation
kinetics. Variation in kinetics behaviour is defined by many
factors, including the concentration of the target DNA and the
immobilized oligonucleotides, duplex length, G+C content and
secondary and tertiary structures in DNA and oligonucleotides [9–
12]. The concentration of the target DNA, the immobilized
oligonucleotides, and the Tm were equivalent for all probes tested.
The influence of the secondary and tertiary structures in
oligonucleotides was reduced by choosing probes that had similar
characteristics for hairpin formation.
DNA microarray development comprises two fundamental
areas: the identification of suitable target probes and the
determination of optimal hybridization conditions. The cassette
approach to probe screening, described in this paper, decreases the
time needed to evaluate individual oligonucleotides because it
allows them to be processed as a batch in a single reaction. This
saving is not insignificant. It can take weeks, or longer, to evaluate
and fine-tune the selection of a series of probes for inclusion in a
biochip, whereas with our approach it takes hours, once the
cassettes have been constructed and prepared. The development
time of any biochip can be considerably shortened using this
strategy, making it more comparable with that for other multiplex
detection systems and other techniques such as probe free nucleic
acid detection using isothermal amplification.
The isothermal amplification techniques, which include Loop-
Mediated Isothermal Amplification (LAMP) [13,14], Helicase-
Dependent Amplification (HDA) [15], Recombinase Polymerase
Amplification (RPA) [16], Rolling Circle Amplification (RCA)
[17], are important innovations in the development of clinical
diagnosis systems, because they can deliver a qualitative positive or
negative response to pathogen detection, particularly when the
target is in low amounts, within a short period of time (circa 1–
2 hour). Of these LAMP and HDA have been developed
commercially [18]. The development of LAMP techniques involve
the design and evaluation of complex primer sets, which limited its
application initially until software was available for the specific
design of these primers [19,20]. Nevertheless, a series of systems
have been designed to detect a range of viral, bacterial and fungal
pathogens using LAMP since then [21], however these cannot
detect multiple targets in a single reaction. The reasons for this
include (1) the use of optical detection, either turbidity or
fluorescence, limits the number of signals that can be observed
(2) interaction between the additional primer pairs [22], and (3)
amplification bias, masking low abundant targets [18]. The
development times for biochips and many isothermal amplification
techniques cannot be readily compared because one is designed to
routinely detect multiple targets in a single reaction, whereas the
other is not. In this respect, reducing the time spent designing and
evaluating probes is an important contribution to the development
of hybridisation biochips.
The detection of low abundant targets, important for clinical
sample screening, presents a specific problem for microarrays in
that pre-amplification steps (gene specific or whole genome) are
necessary before hybridisation. This increases the time needed for
target detection and opens the process to potential contamination
issues. Furthermore, the amplification stages are reliant on PCR
techniques with a requirement for a thermal cycling [23].
Isothermal amplification techniques provide an alternative to
PCR to solve the thermal cycling issue [24], however the current
range of enzymes available for use have slow processivity, often
with methods comprising multiple steps that would lead to
complex and expensive microfluidic consumables [23]. At present
A Novel Cassette Method for Fine-Tuning Biochips
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no isothermal amplification technique has been developed for all
TORCH infections, or to amplify multiple targets in a single
reaction that would be suitable for inclusion in a hybridisation
microarray. A multiplex PCR reaction for TORCH infections has
been described [25], and in this paper we describe a series of
hybridisation probes for a biochip that have been designed and
tested in a relatively short period.
Figure 1. Schematic diagrams and quantitative analysis of the designed cassettes hybridization with biochip. The arrangement of the
probes on the biochips (panels A, B, C, and D) was as follows: a1, a2 – CT1; a3, a4 – HSV; a5 – RV; b1, b2 – CT2; b3, b4 – TOXO1; b5 – RV; c1, c2 – CT3;
c3, c4 – TOXO2; d1, d2 – CMV1; d3, d4 – TOXO3; e1, e2 – CMV2; e3, e4 –TOXO4; e5 – bacterial DNA (negative control); c5, d5 were left empty to give
background signals. White circles represent gene probes that hybridized with the respective targets on the cassette; grey circles represent gene
probes that showed no hybridization and background. Error bars in the histograms are from three replicates and present the results of the Student’s
t-Tests procedure (*p,0.05). Panel (A) Cassette N1 shows the hybridization signals for three Chlamydia trachomatis probes (probes CT1 and CT2), and
for a cryptic plasmid sequence (probe CT3). Panel (B) shows the hybridization signals for the probes CMV1 and CMV2 for Cytomegalovirus, the probe
HSV for Herpes simplex virus (HSV), the TOXO1 probe for Toxoplasma gondii (TOXO1), and the RV probe for Rubela virus (RV) with cassettes N2 (shaded
grey in the histogram) and cassette N3 (shaded black in the histogram). Panel (C) shows the hybridization patterns for the probes TOXO1, TOXO2,
TOXO3 and TOXO4 for Toxoplasma gondii with cassette N4, revealing that the TOXO1 probe was unsuitable for inclusion in the TORCH biochip. Panel
(D) shows the hybridization signals for probes CT1, CMV2, HSV, RV, and TOXO2 with cassette N5.
doi:10.1371/journal.pone.0098596.g001
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Supporting Information
Data S1 The composition and sequences of N1, N2, N3, N4 and
N5 cassettes.
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